Andrew A. Hindman Insider Trading $ACOR ACORDA THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew A. Hindman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew A. Hindman. Andrew A. Hindman is Chief Business Dev. Officer in ACORDA THERAPEUTICS INC ($ACOR) and Chief Business Officer in ACORDA THERAPEUTICS INC ($ACOR) and SVP, Chief Financial Officer in Theravance Biopharma, Inc. ($TBPH).
Andrew A. Hindman in ACORDA THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Andrew A. Hindman: Chief Business Officer, Chief Business Dev. Officer
Holdings: 15,639 shares
Current Value: $331,547
Latest Transaction: Mar 12 2019
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew A. Hindman in ACORDA THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Option Exercise | A | 13.51 | 15,075 | 203,663 | 15,075 | |
| Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 9,045 | 0 | 15,639 | 6.6 K to 15.6 K (+137.17 %) |
| Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 13.38 | 877 | 11,734 | 6,594 | 7.5 K to 6.6 K (-11.74 %) |
| Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 2,300 | 0 | 7,471 | 5.2 K to 7.5 K (+44.48 %) |
| Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Sell | S | 20.56 | 753 | 15,478 | 5,171 | 5.9 K to 5.2 K (-12.71 %) |
| Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 20.28 | 879 | 17,826 | 5,924 | 6.8 K to 5.9 K (-12.92 %) |
| Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 2,300 | 0 | 6,803 | 4.5 K to 6.8 K (+51.08 %) |
| May 30 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Sell | S | 24.26 | 42,615 | 1,034,006 | 4,503 | 47.1 K to 4.5 K (-90.44 %) |
| May 15 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 24.35 | 3,930 | 95,696 | 47,118 | 51 K to 47.1 K (-7.70 %) |
| May 15 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 24.35 | 3,930 | 95,696 | 47,118 | 51 K to 47.1 K (-7.70 %) |
| Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 5,742 | 0 | 51,048 | 45.3 K to 51 K (+12.67 %) |
| Dec 05 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 20.54 | 817 | 16,784 | 45,306 | 46.1 K to 45.3 K (-1.77 %) |
| May 17 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 15.75 | 7,704 | 121,319 | 46,123 | 53.8 K to 46.1 K (-14.31 %) |
| May 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 16.50 | 65,000 | 1,072,500 | 65,000 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 27.48 | 11,500 | 315,963 | 11,500 | |
| Mar 03 2017 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 4,600 | 0 | 53,827 | 49.2 K to 53.8 K (+9.34 %) |
| Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 20.72 | 443 | 9,180 | 49,227 | 49.7 K to 49.2 K (-0.89 %) |
| May 16 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 26.11 | 4,860 | 126,885 | 49,670 | 54.5 K to 49.7 K (-8.91 %) |
| May 13 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 26.40 | 25,000 | 660,000 | 25,000 | |
| Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 35.53 | 26,796 | 952,062 | 26,796 | |
| Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 38.26 | 442 | 16,911 | 54,530 | 55 K to 54.5 K (-0.80 %) |
| May 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 30.16 | 475 | 14,326 | 54,972 | 55.4 K to 55 K (-0.86 %) |
| May 15 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Sell | S | 29.78 | 4,304 | 128,168 | 55,447 | 59.8 K to 55.4 K (-7.20 %) |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 35.74 | 23,885 | 853,650 | 23,885 | |
| Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 4,215 | 0 | 59,751 | 55.5 K to 59.8 K (+7.59 %) |
| Dec 31 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | M | 41.07 | 25,000 | 1,026,750 | 25,000 | |
| May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 30.35 | 27,768 | 842,759 | 27,768 | |
| May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 30.35 | 138,840 | 4,213,794 | 138,840 | |
| May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 9,256 | 0 | 55,536 | 46.3 K to 55.5 K (+20.00 %) |
| May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 46,280 | 0 | 46,280 | 0 to 46.3 K |
Page: 1